Related Experiment Video
Updated: May 6, 2026
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Soybean β-Conglycinin and Cowpea β-Vignin Peptides Inhibit Breast and Prostate Cancer Cell Growth: An In Silico and
Biane Oliveira Philadelpho1, Victória Guimarães Santiago1, Johnnie Elton Machado Dos Santos1
1School of Pharmacy, Federal University of Bahia, Barão de Jeremoabo Street, Salvador 40170-115, BA, Brazil.
Abstract:
B-cell lymphoma 2 protein (Bcl-2) is an important regulator of cell apoptosis. Inhibitors that mirror the structural domain 3 (BH3) of Bcl-2 can activate apoptosis in cancer cells, making them a promising target for anticancer treatment. Hence, the present study aimed to investigate potential BH3-mimetic peptides from two vicilin-derived legume proteins from soybean and cowpea bean. The proteins were isolated and sequentially hydrolyzed with pepsin/pancreatin. Peptides < 3 kDa from vicilin-derived proteins from soybean and cowpea beans experimentally inhibited the growth of cultivated breast and prostate cancer cells. In silico analysis allowed the identification of six potential candidates, all predicted to be able to interact with the BH3 domain. The VIPAAY peptide from the soybean β-conglycinin β subunit showed the highest potential to interact with Bcl-2, comparable to Venetoclax, a well-known anticancer drug. Further experiments are needed to confirm this study's findings.
Insights
Researchers explored legume-derived peptides as potential anticancer agents. A peptide from soybean vicilin showed promise in inhibiting cancer cell growth by mimicking the Bcl-2 protein
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- B-cell lymphoma 2 protein (Bcl-2) regulates apoptosis and is a target for cancer therapy.
- BH3-mimetic peptides can activate apoptosis in cancer cells.
- Legume proteins, such as vicilins from soybean and cowpea, are sources of bioactive peptides.
Purpose of the Study:
- To identify and characterize BH3-mimetic peptides from soybean and cowpea vicilin proteins.
- To evaluate the anticancer potential of these peptides against breast and prostate cancer cells.
- To investigate the interaction of identified peptides with the Bcl-2 protein.
Main Methods:
- Isolation and sequential hydrolysis of vicilin-derived proteins from soybean and cowpea beans.
- Experimental evaluation of peptide efficacy in inhibiting cultivated breast and prostate cancer cell growth.
- In silico analysis to predict peptide interaction with the Bcl-2 BH3 domain.
Main Results:
- Peptides < 3 kDa derived from soybean and cowpea vicilins inhibited breast and prostate cancer cell growth.
- Six potential BH3-mimetic peptides were identified through in silico analysis.
- The peptide VIPAAY from soybean β-conglycinin β subunit demonstrated high potential for Bcl-2 interaction, comparable to Venetoclax.
Conclusions:
- Vicilin-derived peptides from legumes possess anticancer properties.
- The VIPAAY peptide is a promising BH3-mimetic candidate for cancer treatment.
- Further in vivo and clinical studies are warranted to validate these findings.
